Upregulated expression of cardiac endothelin-1 participates in myocardial cell growth in Bio 14.6 Syrian cardiomyopathic hamsters

Journal of the American College of Cardiology

Volumn 33, Issue 2, 1999, Pages 565-571

  Inada, Tsukasa ^a   Fujiwara, Hisayoshi ^a   Hasegawa, Koji ^a   Araki, Makoto ^a   Yamauchi Kohno, Rikako ^b   Yabana, Hideo ^b   Fujiwara, Takako ^c   Tanaka, Masaru ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Lead Optimization Res Laboratory   (Japan)

^c KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL GROWTH; CONTROLLED STUDY; HEART MUSCLE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYRIAN HAMSTER;

ANIMALS; CARDIOMYOPATHY, DILATED; CELL DIVISION; CRICETINAE; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART VENTRICLES; MALE; MESOCRICETUS; MYOCARDIUM; ORGAN SIZE; PYRIMIDINES; RANDOM ALLOCATION; RECEPTORS, ENDOTHELIN; SULFONAMIDES; UP-REGULATION;

EID: 0033081061     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00564-6     Document Type: Article

References (31)

1. Yanagisawa M., Kurihara H., Kimura S., et al. A noble potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
2. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
3. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., et al. Cloning of a cDNA encoding a nonisopeptide-selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
4. Wei C.M., Lerman A., Rodeheffer R.J., et al. Endothelin in human congestive heart failure. Circulation. 89:1994;1580-1586.
5. Cody R.J., Hass G.J., Binkley P.F., Capers Q., Kelley R. Plasma endothelin correlates with extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 85:1992;504-507.
6. Shimoyama H., Sabbah H.N., Borzak S., et al. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure. Circulation. 94:1996;779-784.
7. Kiowski W., Sutsch G., Hunziker P., Muller P., Kim J., Oechslin E., Schmitt R., Jones R., Bertel O. Evidence for endothelin-1-mediated vasoconstriction severe chronic heart failure. Lancet. 346:1995;732-736.
8. Haynes W.G., Webb D.J. The endothelin family of peptides local hormones with diverse roles in health and disease. Clin Sci. 84:1993;485-500.
9. Shubeita H.E., McDonough P.M., Harris A.N., et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes a paracrine mechanism for myocardial cell hypertrophy . J Biol Chem. 25:1990;20,555-20,562.
10. Ito H., Hirata Y., Hiroe M., et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 69:1991;209-215.
11. Yamazaki T., Komuro I., Kudoh S., Zou Y., Shiojima I., Hiroi Y., Mizuno T., Maemura K., Kurihara H., Aikawa R., Tanaka H., Yazaki Y. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem. 271:1996;3221-3228.
12. A receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation. 89:1994;2198-2203.
13. Sakai S., Miyauchi T., Kobayashi M., Goto K., Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature. 384:1996;353-355.
14. Hasegawa K., Fujiwara H., Koshiji M., Inada T., Ohtani S., Doyama K., Tanaka M., Matsumori A., Fujiwara T., Shirakami G., Hosoda K., Nakao K., Sasayama S. Endothelin-1 and its receptor in hypertrophic cardiomyopathy. Hypertension. 27:1996;259-264.
15. Kitamura K., Tanaka J., Kato T., Ogawa T., Eto T., Tanaka K. Immunoreactive endothelin in rat kidney inner medulla marked decrease in spontaneously hypertensive rats. Biochem Biophys Res Commun. 156:1989;1182-1186.
16. Hasegawa K., Fujiwara H., Doyama K., et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation. 88:1993;372-380.
17. Hoshino T., Fujiwara H., Kawai C., Hamashima Y. Myocardial fiber diameter and regional distribution in the ventricular wall of normal adult hearts, hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation. 67:1983;1109-1116.
18. Fujiwara H., Hoshino T., Yamana K., et al. Number and size of myocytes and amount of interstitial space in the ventricular septum and in the left ventricular free wall in hypertrophic cardiomyopathy. Am J Cardiol. 52:1983;818-823.
19. Uegaito T., Fujiwara H., Ishida M., et al. Hypertrophy of surviving myocytes overlying the infarct in human old myocardial infarctions with abnormal Q waves. Int J Cardiol. 32:1991;93-102.
20. Tanaka M., Fujiwara H., Onodera T., Wu D.J., Hamashima Y., Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J. 55:1986;575-581.
21. Onodera T., Fujiwara H., Tanaka M., Wu D.J., Hamashima Y., Kawai C. Quantitative analysis of cardiac fibrosis in normal hearts, hearts with secondary eccentric hypertrophy and hearts with dilated cardiomyopathy. Card-Ang Bull. 3:1986;53-59.
22. Ito H., Hirata Y., Adachi M., et al. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 92:1993;398-403.
23. Gertz E.W. Cardiomyopathic syrian hamster a possible model of human disease. Prog Exp Tumor Res. 16:1972;242-260.
24. Haynes W.G., Webb D.J. The endothelin family of peptides local hormones with diverse roles in health and disease? Clin Sci. 84:1993;485-500.
25. Rouleau J.L., Chuck L.H., Hollosi G., et al. Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster. Circ Res. 50:1982;405-412.
26. Ikegaya T., Nishiyama T., Kobayashi A., Yamazaki N. Role of alpha 1-adrenergic receptors and the effect of bunazosin on the histopathology of cardiomyopathic Syrian hamsters of strain BIO 14.6. Jpn Circ. 52:1988;181-187.
27. 1-adrenergic stimulated hypertrophy in cultured neonatal rat cardiac myocytes. Circulation in press.
28. Kobayashi A., Yamashita T., Kaneko M., et al. Effects of verapamil on experimental cardiomyopathy in the Bio 14.6 Syrian hamster. J Am Coll Cardiol. 10:1987;1128-1138.
29. Uusimaa P.A., Hassinen I.E., Vuolteenaho O., Ruskoaho H. Endothelin-induced atrial natriuretic peptide release from cultured neonatal cardiac myocytes the role of extracellular calcium and protein kinase-C. Endocrinology. 130:1992;2455-2464.
30. Haleen S.J., Weishaar R.E., Overhiser R.W., et al. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster-Hemodynamic, morphological, and biochemical correlates. Circ Res. 68:1991;1302-1312.
31. Geisterfer-Lowrance A.A.T., Kass S., Tanigawa G., et al. A molecular basis for familiar hypertrophic cardiomyopathy a β cardiac myosin heavy chain gene missense mutation. Cell. 62:1990;999-1006.